Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study.
|Title||Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study.|
|Publication Type||Journal Article|
|Year of Publication||2004|
|Authors||Emslie, GJ, Heiligenstein JH, Hoog SL, Wagner KD, Findling RL, McCracken JT, Nilsson ME, Jacobson JG|
|Journal||Journal of the American Academy of Child and Adolescent Psychiatry|
|Date Published||2004 Nov|
|Keywords||Administration, Oral, Adolescent, Child, Depressive Disorder, Double-Blind Method, Female, Fluoxetine, Humans, Male, Placebos, Recurrence, Serotonin Uptake Inhibitors|
To compare fluoxetine 20 to 60 mg/day with placebo for prevention of relapse of major depressive disorder in children and adolescents who had achieved Children's Depression Rating Scale, Revised scores of < or =28 during treatment with fluoxetine 20 to 60 mg.
|Alternate Journal||J Am Acad Child Adolesc Psychiatry|